Variant report
Variant | rs1077432 |
---|---|
Chromosome Location | chr6:29782868-29782869 |
allele | C/T |
Outlinks | Ensembl   UCSC |
- TF binding region (count:32)
- CpG islands (count:0)
- Chromatin interactive region (count:8)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:32 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | HEY1 | chr6:29782343-29783082 | K562 | blood: | n/a | n/a |
2 | POLR2A | chr6:29782439-29783136 | K562 | blood: | n/a | n/a |
3 | GATA1 | chr6:29782685-29783366 | PBDE | blood: | n/a | n/a |
4 | EP300 | chr6:29782783-29783116 | GM12878 | blood: | n/a | n/a |
5 | IRF1 | chr6:29782834-29783099 | K562 | blood: | n/a | chr6:29782967-29782984 chr6:29782969-29782983 chr6:29782973-29782983 chr6:29782868-29782882 |
6 | TAL1 | chr6:29782077-29783289 | K562 | blood: | n/a | n/a |
7 | MYC | chr6:29782714-29783082 | K562 | blood: | n/a | n/a |
8 | ZBTB7A | chr6:29782527-29783168 | K562 | blood: | n/a | chr6:29783010-29783018 |
9 | BCLAF1 | chr6:29782595-29783110 | K562 | blood: | n/a | n/a |
10 | GTF2F1 | chr6:29782812-29783122 | K562 | blood: | n/a | n/a |
11 | GTF2B | chr6:29782763-29783117 | K562 | blood: | n/a | n/a |
12 | POLR2A | chr6:29782635-29783132 | K562 | blood: | n/a | n/a |
13 | PML | chr6:29782466-29783099 | K562 | blood: | n/a | n/a |
14 | PML | chr6:29782588-29783167 | K562 | blood: | n/a | n/a |
15 | TEAD4 | chr6:29782714-29783265 | K562 | blood: | n/a | n/a |
16 | CBX3 | chr6:29782203-29783230 | K562 | blood: | n/a | n/a |
17 | POLR2A | chr6:29782465-29783139 | K562 | blood: | n/a | n/a |
18 | ZNF143 | chr6:29782815-29783293 | K562 | blood: | n/a | n/a |
19 | POLR2A | chr6:29782424-29783143 | K562 | blood: | n/a | n/a |
20 | GATA2 | chr6:29782856-29783247 | K562 | blood: | n/a | n/a |
21 | HEY1 | chr6:29782550-29783054 | K562 | blood: | n/a | n/a |
22 | TBL1XR1 | chr6:29782831-29783031 | K562 | blood: | n/a | n/a |
23 | TEAD4 | chr6:29782577-29783272 | K562 | blood: | n/a | n/a |
24 | TBP | chr6:29782765-29783192 | K562 | blood: | n/a | n/a |
25 | ZMIZ1 | chr6:29782692-29783111 | K562 | blood: | n/a | n/a |
26 | POLR2A | chr6:29782543-29783056 | K562 | blood: | n/a | n/a |
27 | USF1 | chr6:29782717-29783101 | K562 | blood: | n/a | n/a |
28 | BCLAF1 | chr6:29782754-29783154 | K562 | blood: | n/a | n/a |
29 | TAF7 | chr6:29782637-29783108 | K562 | blood: | n/a | n/a |
30 | TAF7 | chr6:29782726-29782971 | K562 | blood: | n/a | n/a |
31 | POLR2A | chr6:29782416-29783123 | K562 | blood: | n/a | n/a |
32 | MAX | chr6:29782582-29783086 | K562 | blood: | n/a | n/a |
No data |
(count:8 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:29762168..29764765-chr6:29782319..29784097,2 | K562 | blood: | |
2 | chr6:29691597..29693774-chr6:29780569..29783300,2 | MCF-7 | breast: | |
3 | chr6:29778199..29781037-chr6:29781139..29783059,2 | K562 | blood: | |
4 | chr6:29721629..29723965-chr6:29782354..29784325,2 | K562 | blood: | |
5 | chr6:29776748..29779241-chr6:29782006..29784779,2 | K562 | blood: | |
6 | chr6:29780662..29785245-chr6:29788028..29791562,7 | K562 | blood: | |
7 | chr6:29712194..29714049-chr6:29781280..29783856,2 | K562 | blood: | |
8 | chr6:29755654..29758226-chr6:29780556..29783054,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
MICG | TF binding region |
ENSG00000225864 | Chromatin interaction |
ENSG00000204642 | Chromatin interaction |
ENSG00000237042 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs1077433 | 0.99[AFR][1000 genomes];1.00[AMR][1000 genomes];0.97[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs1079599 | 0.99[AFR][1000 genomes];1.00[AMR][1000 genomes];0.97[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs1111673 | 0.99[AFR][1000 genomes];1.00[AMR][1000 genomes];0.97[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs1155143 | 0.94[AFR][1000 genomes];0.89[AMR][1000 genomes];0.86[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs1318083 | 0.99[AFR][1000 genomes];1.00[AMR][1000 genomes];0.97[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs1610654 | 0.87[EUR][1000 genomes] |
rs1610655 | 0.89[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs1610658 | 0.85[AMR][1000 genomes];0.89[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs1610659 | 0.85[AMR][1000 genomes];0.89[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs1610661 | 0.85[AMR][1000 genomes];0.89[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs1610662 | 0.81[AFR][1000 genomes];0.88[AMR][1000 genomes];0.88[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs1610663 | 0.82[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs1610664 | 0.82[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs1610665 | 0.81[AFR][1000 genomes];0.91[AMR][1000 genomes];0.89[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs1610666 | 0.89[AFR][1000 genomes];0.92[AMR][1000 genomes];0.95[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs1610667 | 0.87[AFR][1000 genomes];0.92[AMR][1000 genomes];0.97[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs1610668 | 0.88[EUR][1000 genomes] |
rs1610673 | 0.97[AFR][1000 genomes];1.00[AMR][1000 genomes];0.97[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs1610674 | 0.83[AFR][1000 genomes];0.91[AMR][1000 genomes];0.94[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs1610675 | 0.94[AFR][1000 genomes];0.89[AMR][1000 genomes];0.86[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs1610682 | 0.81[ASN][1000 genomes] |
rs1610696 | 0.85[AFR][1000 genomes];0.89[AMR][1000 genomes];0.86[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs1610697 | 0.82[AFR][1000 genomes];0.88[AMR][1000 genomes];0.89[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs1610698 | 0.81[AFR][1000 genomes];0.88[AMR][1000 genomes];0.89[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs1610699 | 0.81[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs1610700 | 0.97[AFR][1000 genomes];0.97[AMR][1000 genomes];0.96[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs1610702 | 0.85[ASN][1000 genomes] |
rs1610704 | 0.89[AFR][1000 genomes];0.91[AMR][1000 genomes];0.94[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs1610709 | 0.85[EUR][1000 genomes] |
rs1610710 | 0.87[EUR][1000 genomes] |
rs1610711 | 0.82[AMR][1000 genomes];0.88[EUR][1000 genomes] |
rs1610714 | 0.80[AMR][1000 genomes];0.88[EUR][1000 genomes] |
rs1610715 | 0.89[EUR][1000 genomes];0.84[ASN][1000 genomes] |
rs1611139 | 0.85[AFR][1000 genomes];0.89[AMR][1000 genomes];0.86[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs1611142 | 0.81[AFR][1000 genomes] |
rs1611143 | 0.87[AFR][1000 genomes];0.92[AMR][1000 genomes];0.95[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs1611158 | 0.93[AFR][1000 genomes];0.88[AMR][1000 genomes];0.85[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs1611159 | 0.93[AFR][1000 genomes];0.89[AMR][1000 genomes];0.86[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs1611162 | 0.93[AFR][1000 genomes];0.86[AMR][1000 genomes];0.85[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs1611166 | 0.81[AFR][1000 genomes] |
rs1611172 | 0.81[AFR][1000 genomes];0.85[AMR][1000 genomes];0.87[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs1611175 | 0.81[AFR][1000 genomes];0.85[AMR][1000 genomes];0.87[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs1611176 | 0.83[EUR][1000 genomes];0.84[ASN][1000 genomes] |
rs1611180 | 0.83[AMR][1000 genomes];0.85[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs1611184 | 0.97[AFR][1000 genomes];1.00[AMR][1000 genomes];0.97[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs1611191 | 0.85[AMR][1000 genomes];0.89[EUR][1000 genomes];0.84[ASN][1000 genomes] |
rs1611195 | 0.85[AMR][1000 genomes];0.89[EUR][1000 genomes];0.84[ASN][1000 genomes] |
rs1620173 | 0.99[AFR][1000 genomes];0.97[AMR][1000 genomes];0.96[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs1624302 | 0.85[AMR][1000 genomes];0.89[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs1629068 | 0.84[EUR][1000 genomes] |
rs1630969 | 0.84[EUR][1000 genomes] |
rs1632949 | 0.87[AFR][1000 genomes] |
rs1632950 | 0.90[AFR][1000 genomes] |
rs1632973 | 0.88[AMR][1000 genomes];0.89[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs1632976 | 0.88[AMR][1000 genomes];0.89[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs1632977 | 0.81[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs1632978 | 0.81[EUR][1000 genomes] |
rs1632979 | 0.88[AMR][1000 genomes];0.88[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs1632987 | 0.85[AMR][1000 genomes];0.89[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs1632988 | 0.82[AMR][1000 genomes];0.87[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs1632997 | 0.85[EUR][1000 genomes] |
rs1633000 | 0.82[EUR][1000 genomes] |
rs1633002 | 0.84[EUR][1000 genomes] |
rs1633004 | 0.84[EUR][1000 genomes] |
rs1633006 | 0.85[EUR][1000 genomes] |
rs1633007 | 0.85[EUR][1000 genomes] |
rs1633039 | 0.91[AFR][1000 genomes];0.91[AMR][1000 genomes];0.85[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs1633047 | 0.94[AFR][1000 genomes];0.92[AMR][1000 genomes];0.85[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs1633108 | 0.98[AFR][1000 genomes];0.83[AMR][1000 genomes] |
rs1736934 | 0.87[AFR][1000 genomes] |
rs1736937 | 0.87[AFR][1000 genomes] |
rs1736939 | 0.87[AFR][1000 genomes] |
rs1736942 | 0.92[AFR][1000 genomes];0.89[AMR][1000 genomes];0.86[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs1736948 | 0.94[AFR][1000 genomes];0.92[AMR][1000 genomes];0.86[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs1736950 | 0.94[AFR][1000 genomes];0.91[AMR][1000 genomes];0.85[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs1736955 | 0.99[AFR][1000 genomes];1.00[AMR][1000 genomes];0.97[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs1736957 | 0.85[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs1736958 | 0.99[AFR][1000 genomes];1.00[AMR][1000 genomes];0.97[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs1736959 | 0.99[AFR][1000 genomes];1.00[AMR][1000 genomes];0.97[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs1736963 | 0.88[AMR][1000 genomes];0.89[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs1736964 | 0.88[AMR][1000 genomes];0.89[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs1736966 | 0.88[AMR][1000 genomes];0.89[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs1736967 | 0.88[AMR][1000 genomes];0.89[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs1736968 | 0.88[AMR][1000 genomes];0.89[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs1736969 | 0.88[AMR][1000 genomes];0.89[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs1736970 | 0.82[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs1736971 | 0.88[AMR][1000 genomes];0.89[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs1736972 | 0.88[AMR][1000 genomes];0.89[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs1736973 | 0.88[AMR][1000 genomes];0.89[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs1736974 | 0.88[AMR][1000 genomes];0.89[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs1736975 | 0.88[AMR][1000 genomes];0.88[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs1736983 | 0.88[EUR][1000 genomes] |
rs1736985 | 0.88[EUR][1000 genomes] |
rs1736986 | 0.87[EUR][1000 genomes] |
rs1737000 | 0.85[EUR][1000 genomes] |
rs2248870 | 0.85[AMR][1000 genomes];0.88[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs2248871 | 0.85[AMR][1000 genomes];0.88[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs2517919 | 0.84[AMR][1000 genomes];0.87[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs2517920 | 0.84[AMR][1000 genomes];0.87[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs2523408 | 0.81[ASN][1000 genomes] |
rs2523410 | 0.85[AMR][1000 genomes];0.86[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs2735024 | 0.88[AFR][1000 genomes] |
rs2735029 | 0.88[AMR][1000 genomes];0.89[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs28514417 | 0.85[EUR][1000 genomes] |
rs753544 | 0.96[AFR][1000 genomes];0.98[AMR][1000 genomes];0.96[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs9258448 | 0.85[AMR][1000 genomes];0.88[EUR][1000 genomes];0.88[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | esv20940 | chr6:29653954-29923410 | Flanking Active TSS Strong transcription Flanking Bivalent TSS/Enh Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Genic enhancers Bivalent/Poised TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 46 gene(s) | inside rSNPs | diseases |
2 | nsv428139 | chr6:29659525-29892317 | Bivalent Enhancer Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Weak transcription Strong transcription Flanking Bivalent TSS/Enh Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 41 gene(s) | inside rSNPs | diseases |
3 | nsv427749 | chr6:29659525-29975144 | Enhancers Active TSS Strong transcription Flanking Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 53 gene(s) | inside rSNPs | diseases |
4 | nsv10809 | chr6:29692573-29794119 | Flanking Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription Genic enhancers Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNA | 26 gene(s) | inside rSNPs | diseases |
5 | nsv883532 | chr6:29703262-29814963 | Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Weak transcription Genic enhancers Strong transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 25 gene(s) | inside rSNPs | diseases |
6 | esv3441842 | chr6:29715749-29942950 | Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Strong transcription Bivalent/Poised TSS Active TSS Genic enhancers Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 47 gene(s) | inside rSNPs | diseases |
7 | esv11180 | chr6:29729381-29800066 | Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Strong transcription ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNA | 16 gene(s) | inside rSNPs | diseases |
8 | esv3332677 | chr6:29733187-29961463 | Flanking Active TSS Enhancers Weak transcription Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Strong transcription Genic enhancers ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 43 gene(s) | inside rSNPs | diseases |
9 | esv3423001 | chr6:29733216-29878601 | Enhancers Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers Strong transcription | TF binding regionCpG islandChromatin interactive regionlncRNA | 32 gene(s) | inside rSNPs | diseases |
10 | esv3475027 | chr6:29733297-29922699 | Bivalent Enhancer Weak transcription Strong transcription Flanking Bivalent TSS/Enh Genic enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Enhancers ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 38 gene(s) | inside rSNPs | diseases |
11 | esv3475028 | chr6:29733297-29922699 | Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Active TSS Bivalent/Poised TSS Strong transcription Genic enhancers ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 38 gene(s) | inside rSNPs | diseases |
12 | esv3420260 | chr6:29734457-29835593 | Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription Strong transcription ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 25 gene(s) | inside rSNPs | diseases |
13 | esv3330285 | chr6:29736281-29881328 | Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription Active TSS Bivalent Enhancer ZNF genes & repeats Genic enhancers Strong transcription | TF binding regionCpG islandChromatin interactive regionlncRNA | 31 gene(s) | inside rSNPs | diseases |
14 | esv3396224 | chr6:29754243-29888093 | Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Active TSS ZNF genes & repeats Strong transcription Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 30 gene(s) | inside rSNPs | diseases |
15 | nsv965702 | chr6:29758408-29798943 | Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Strong transcription Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 11 gene(s) | inside rSNPs | diseases |
16 | esv3430372 | chr6:29759523-29974277 | Genic enhancers Enhancers Active TSS Bivalent/Poised TSS Flanking Active TSS Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Strong transcription Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 42 gene(s) | inside rSNPs | diseases |
17 | esv3426050 | chr6:29761594-29918407 | Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers ZNF genes & repeats Bivalent/Poised TSS Weak transcription Transcr. at gene 5' and 3' Active TSS Genic enhancers Strong transcription | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 34 gene(s) | inside rSNPs | diseases |
18 | esv3431350 | chr6:29765473-29922767 | Strong transcription Active TSS Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 34 gene(s) | inside rSNPs | diseases |
19 | nsv883540 | chr6:29772395-29784317 | Weak transcription Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 5 gene(s) | inside rSNPs | diseases |
20 | esv3354193 | chr6:29773857-29867902 | Weak transcription Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Enhancers Strong transcription Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 25 gene(s) | inside rSNPs | diseases |
21 | esv3451016 | chr6:29774115-29929436 | Strong transcription Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 32 gene(s) | inside rSNPs | diseases |
22 | esv3369144 | chr6:29775824-29872385 | Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Weak transcription Transcr. at gene 5' and 3' Strong transcription Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNA | 26 gene(s) | inside rSNPs | diseases |
23 | esv3500392 | chr6:29777854-29871802 | Flanking Active TSS Bivalent/Poised TSS Strong transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Weak transcription Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 25 gene(s) | inside rSNPs | diseases |
24 | esv3500393 | chr6:29777854-29871802 | Active TSS Bivalent Enhancer Flanking Active TSS Enhancers Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats Strong transcription | TF binding regionCpG islandChromatin interactive regionlncRNA | 25 gene(s) | inside rSNPs | diseases |
25 | esv3352548 | chr6:29777973-29783971 | Enhancers Bivalent Enhancer Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | inside rSNPs | diseases |
26 | esv3384912 | chr6:29778488-29872579 | ZNF genes & repeats Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Active TSS Bivalent/Poised TSS Weak transcription Enhancers Genic enhancers Transcr. at gene 5' and 3' Strong transcription | TF binding regionCpG islandChromatin interactive regionlncRNA | 25 gene(s) | inside rSNPs | diseases |
27 | esv3431922 | chr6:29779132-29873171 | Flanking Bivalent TSS/Enh Active TSS Weak transcription Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 25 gene(s) | inside rSNPs | diseases |
28 | esv3338581 | chr6:29780045-29890754 | Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Strong transcription Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 26 gene(s) | inside rSNPs | diseases |
29 | esv17468 | chr6:29782014-29923275 | Flanking Active TSS Active TSS Bivalent/Poised TSS Enhancers Strong transcription Transcr. at gene 5' and 3' Weak transcription Flanking Bivalent TSS/Enh ZNF genes & repeats Genic enhancers Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 31 gene(s) | inside rSNPs | diseases |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:29779400-29783800 | Weak transcription | Right Atrium | heart |
2 | chr6:29781000-29783600 | Enhancers | K562 | blood |
3 | chr6:29782000-29783400 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
4 | chr6:29782000-29783600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
5 | chr6:29782000-29783800 | Weak transcription | NHEK | skin |
6 | chr6:29782600-29783000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
7 | chr6:29782800-29784000 | Weak transcription | HMEC | breast |